About
Scholar Rock Holding Corp (NASDAQ:SRRK) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026
Mar 31 2026
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
Mar 3 2026
CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Feb 10 2026
Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
Jan 16 2026
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Financials
Revenue
$0
Market Cap
$5.75 B
EPS
-3.29
Translate